Here's how EURJMEDRES.BIOMEDCENTRAL.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

EURJMEDRES . BIOMEDCENTRAL . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Eurjmedres.biomedcentral.com Make Money
  6. How Much Does Eurjmedres.biomedcentral.com Make
  7. Keywords
  8. Topics
  9. Schema
  10. Social Networks
  11. External Links
  12. Analytics And Tracking
  13. Libraries

We are analyzing https://eurjmedres.biomedcentral.com/articles/10.1186/s40001-023-01016-7.

Title:
Integrated investigation of the clinical implications and targeted landscape for RNA methylation modifications in hepatocellular carcinoma | European Journal of Medical Research | Full Text
Description:
Background RNA methylation (RM) is a crucial post-translational modification (PTM) that directs epigenetic regulation. It mostly consists of N1-methyladenosine (m1A), 5-methylcytosine (m5C), N3-methylcytidine (m3C), N6-methyladenosine (m6A), and 2′-O-methylation (Nm). The “writers” mainly act as intermediaries between these modifications and associated biological processes. However, little is known about the interactions and potential functions of these RM writers in hepatocellular carcinoma (HCC). Methods The expression properties and genetic alterations of 38 RM writers were assessed in HCC samples from five bioinformatic datasets. Two patterns associated with RM writers were identified using consensus clustering. Then, utilizing differentially expressed genes (DEGs) from different RM subtypes, we built a risk model called RM_Score. Additionally, we investigated the correlation of RM_Score with clinical characteristics, tumor microenvironment (TME) infiltration, molecular subtypes, therapeutic response, immunotherapy effectiveness, and competing endogenous RNA (ceRNA) network. Results RM writers were correlated with TME cell infiltration and prognosis. Cluster_1/2 and gene.cluster_A/B were shown to be capable of distinguishing the HCC patients with poor prognosis after consensus and unsupervised clustering of RNA methylation writers. Additionally, we constructed RNA modification pattern-specific risk model and subdivided the cases into RM_Score high and RM_Score low subgroups. In individual cohorts or merged datasets, the high RM_Score was related to a worse overall survival of HCC patients. RM_Score also exhibited correlations with immune and proliferation related pathways. In response to anti-cancer treatments, the RM_Score had a negative correlation (drug sensitive) with drugs that focused on the MAPK/ERK and metabolism signaling, and a positive correlation (drug resistant) with compounds targeting RKT and PI3K/mTOR signaling pathway. Notably, the RM_Score was connected to the therapeutic effectiveness of PD-L1 blockage, implying that RM writers may be the target of immunotherapy to optimize clinical outcomes. Additionally, a ceRNA network was generated including 2 lncRNAs, 4 miRNAs, and 7 mRNAs that was connected to RM writers. Conclusions We thoroughly investigated the potential functions of RNA methylation writers and established an RM_patterns-based risk model for HCC patients. This study emphasized the critical functions of RM modification in TME infiltration, targeted therapy, and immunotherapy, providing potential targets for HCC.
Website Age:
25 years and 10 months (reg. 1999-08-06).

Matching Content Categories {📚}

  • Science
  • TV
  • Education

Content Management System {📝}

What CMS is eurjmedres.biomedcentral.com built with?

Custom-built

No common CMS systems were detected on Eurjmedres.biomedcentral.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of eurjmedres.biomedcentral.com audience?

🚀 Good Traffic: 50k - 100k visitors per month


Based on our best estimate, this website will receive around 50,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Eurjmedres.biomedcentral.com Make Money? {💸}


Display Ads {🎯}


The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.

Ads are managed by yourbow.com. Particular relationships are as follows:

Direct Advertisers (3)
yourbow.com, google.com, doceree.com

How Much Does Eurjmedres.biomedcentral.com Make? {💰}


Display Ads {🎯}

$690 per month
According to our algorithms, Eurjmedres.biomedcentral.com's monthly online income from display advertising ranges from $462 to $1,271.

Keywords {🔍}

rmscore, writers, rna, hcc, fig, methylation, article, analysis, cancer, modification, patients, google, scholar, immune, expression, cell, table, cluster, high, survival, cas, nsun, additional, tumor, cohort, file, carcinoma, low, hepatocellular, correlation, drug, mutation, clinical, cohorts, liver, mettl, sensitivity, degs, model, pathways, zhang, infiltration, response, immunotherapy, signaling, group, gene, clustering, tme, potential,

Topics {✒️}

cbx3-mediated c-met/akt/mtor axis sum {pc}_{1}+\sum {pc}_{2} hur-ets1-p21/p27 axis m6a-hur-dependent epigenetic silencing account european journal mir-522–3p/socs5 axis generate mrna–mirna–lncrna network pi3k/akt/mtor signaling ube2c-mediated p53 ubiquitination cancer genome atlas kaplan–meier curves demonstrating kaplan–meier curves show activating akt/mtor signaling pi3k/mtor signaling pathway rna methylation-based classifier rm_patterns-based risk model 2′-o-methylation writer fibrillarin fast-growing hepatocellular carcinomas rna methylation-based model anti-pd-l1 blockers crucial post-translational modification interferon α/γ response rna methylation-related genes rm writers-related signature including includes n1-methyladenosine european economic area multi-center clinical cohorts pd-l1 blockade immunotherapy metastatic urothelial carcinoma rna modification profile anti-pd-l1 treatment mirna–mrna interactions overlapped privacy choices/manage cookies bmc bioinformatics rm writer signature rm phenotype-related degs forecast tumor microenvironment a-related gene expression authors scientific editing univariate cox analysis foxo3-mediated autophagy rna methylation phenotype conducted gsva enrichment analysis protein–rna interactions [5 rna methylation modifications post-translational modification rna methylation modification kaplan–meier method rna methylation model rna methylated modification

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Integrated investigation of the clinical implications and targeted landscape for RNA methylation modifications in hepatocellular carcinoma
         description:RNA methylation (RM) is a crucial post-translational modification (PTM) that directs epigenetic regulation. It mostly consists of N1-methyladenosine (m1A), 5-methylcytosine (m5C), N3-methylcytidine (m3C), N6-methyladenosine (m6A), and 2′-O-methylation (Nm). The “writers” mainly act as intermediaries between these modifications and associated biological processes. However, little is known about the interactions and potential functions of these RM writers in hepatocellular carcinoma (HCC). The expression properties and genetic alterations of 38 RM writers were assessed in HCC samples from five bioinformatic datasets. Two patterns associated with RM writers were identified using consensus clustering. Then, utilizing differentially expressed genes (DEGs) from different RM subtypes, we built a risk model called RM_Score. Additionally, we investigated the correlation of RM_Score with clinical characteristics, tumor microenvironment (TME) infiltration, molecular subtypes, therapeutic response, immunotherapy effectiveness, and competing endogenous RNA (ceRNA) network. RM writers were correlated with TME cell infiltration and prognosis. Cluster_1/2 and gene.cluster_A/B were shown to be capable of distinguishing the HCC patients with poor prognosis after consensus and unsupervised clustering of RNA methylation writers. Additionally, we constructed RNA modification pattern-specific risk model and subdivided the cases into RM_Score high and RM_Score low subgroups. In individual cohorts or merged datasets, the high RM_Score was related to a worse overall survival of HCC patients. RM_Score also exhibited correlations with immune and proliferation related pathways. In response to anti-cancer treatments, the RM_Score had a negative correlation (drug sensitive) with drugs that focused on the MAPK/ERK and metabolism signaling, and a positive correlation (drug resistant) with compounds targeting RKT and PI3K/mTOR signaling pathway. Notably, the RM_Score was connected to the therapeutic effectiveness of PD-L1 blockage, implying that RM writers may be the target of immunotherapy to optimize clinical outcomes. Additionally, a ceRNA network was generated including 2 lncRNAs, 4 miRNAs, and 7 mRNAs that was connected to RM writers. We thoroughly investigated the potential functions of RNA methylation writers and established an RM_patterns-based risk model for HCC patients. This study emphasized the critical functions of RM modification in TME infiltration, targeted therapy, and immunotherapy, providing potential targets for HCC.
         datePublished:2023-01-27T00:00:00Z
         dateModified:2023-01-27T00:00:00Z
         pageStart:1
         pageEnd:15
         license:http://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s40001-023-01016-7
         keywords:
            RNA methylation
            Writer
            Hepatocellular carcinoma
            Tumor microenvironment
            RM_Score
            Drug sensitivity
            Immunotherapy
            Medicine/Public Health
            general
            Infectious Diseases
            Internal Medicine
            Surgery
            Oncology
            Biomedicine
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-023-01016-7/MediaObjects/40001_2023_1016_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-023-01016-7/MediaObjects/40001_2023_1016_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-023-01016-7/MediaObjects/40001_2023_1016_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-023-01016-7/MediaObjects/40001_2023_1016_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-023-01016-7/MediaObjects/40001_2023_1016_Fig5_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-023-01016-7/MediaObjects/40001_2023_1016_Fig6_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-023-01016-7/MediaObjects/40001_2023_1016_Fig7_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-023-01016-7/MediaObjects/40001_2023_1016_Fig8_HTML.png
         isPartOf:
            name:European Journal of Medical Research
            issn:
               2047-783X
            volumeNumber:28
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Jianping Zhang
               affiliation:
                     name:Medical School of Nantong University
                     address:
                        name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
                        type:PostalAddress
                     type:Organization
                     name:Affiliated Hospital of Nanjing University Medical School
                     address:
                        name:Department of Oncology, Yancheng First Hospital, Affiliated Hospital of Nanjing University Medical School, Yancheng, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jie Gao
               affiliation:
                     name:Medical School of Nantong University
                     address:
                        name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
                        type:PostalAddress
                     type:Organization
                     name:Affiliated Hospital of Nanjing University Medical School
                     address:
                        name:Department of Oncology, Yancheng First Hospital, Affiliated Hospital of Nanjing University Medical School, Yancheng, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mingchao Hu
               affiliation:
                     name:Medical School of Nantong University
                     address:
                        name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
                        type:PostalAddress
                     type:Organization
                     name:Medical School of Nantong University
                     address:
                        name:Department of Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Shiyu Xu
               affiliation:
                     name:Medical School of Nantong University
                     address:
                        name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Chun Cheng
               affiliation:
                     name:Medical School of Nantong University
                     address:
                        name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
                        type:PostalAddress
                     type:Organization
                     name:Medical School of Nantong University
                     address:
                        name:Department of Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Wenjie Zheng
               affiliation:
                     name:Medical School of Nantong University
                     address:
                        name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
                        type:PostalAddress
                     type:Organization
                     name:Medical School of Nantong University
                     address:
                        name:Department of Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Jie Zhang
               affiliation:
                     name:Medical School of Nantong University
                     address:
                        name:Department of Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Integrated investigation of the clinical implications and targeted landscape for RNA methylation modifications in hepatocellular carcinoma
      description:RNA methylation (RM) is a crucial post-translational modification (PTM) that directs epigenetic regulation. It mostly consists of N1-methyladenosine (m1A), 5-methylcytosine (m5C), N3-methylcytidine (m3C), N6-methyladenosine (m6A), and 2′-O-methylation (Nm). The “writers” mainly act as intermediaries between these modifications and associated biological processes. However, little is known about the interactions and potential functions of these RM writers in hepatocellular carcinoma (HCC). The expression properties and genetic alterations of 38 RM writers were assessed in HCC samples from five bioinformatic datasets. Two patterns associated with RM writers were identified using consensus clustering. Then, utilizing differentially expressed genes (DEGs) from different RM subtypes, we built a risk model called RM_Score. Additionally, we investigated the correlation of RM_Score with clinical characteristics, tumor microenvironment (TME) infiltration, molecular subtypes, therapeutic response, immunotherapy effectiveness, and competing endogenous RNA (ceRNA) network. RM writers were correlated with TME cell infiltration and prognosis. Cluster_1/2 and gene.cluster_A/B were shown to be capable of distinguishing the HCC patients with poor prognosis after consensus and unsupervised clustering of RNA methylation writers. Additionally, we constructed RNA modification pattern-specific risk model and subdivided the cases into RM_Score high and RM_Score low subgroups. In individual cohorts or merged datasets, the high RM_Score was related to a worse overall survival of HCC patients. RM_Score also exhibited correlations with immune and proliferation related pathways. In response to anti-cancer treatments, the RM_Score had a negative correlation (drug sensitive) with drugs that focused on the MAPK/ERK and metabolism signaling, and a positive correlation (drug resistant) with compounds targeting RKT and PI3K/mTOR signaling pathway. Notably, the RM_Score was connected to the therapeutic effectiveness of PD-L1 blockage, implying that RM writers may be the target of immunotherapy to optimize clinical outcomes. Additionally, a ceRNA network was generated including 2 lncRNAs, 4 miRNAs, and 7 mRNAs that was connected to RM writers. We thoroughly investigated the potential functions of RNA methylation writers and established an RM_patterns-based risk model for HCC patients. This study emphasized the critical functions of RM modification in TME infiltration, targeted therapy, and immunotherapy, providing potential targets for HCC.
      datePublished:2023-01-27T00:00:00Z
      dateModified:2023-01-27T00:00:00Z
      pageStart:1
      pageEnd:15
      license:http://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s40001-023-01016-7
      keywords:
         RNA methylation
         Writer
         Hepatocellular carcinoma
         Tumor microenvironment
         RM_Score
         Drug sensitivity
         Immunotherapy
         Medicine/Public Health
         general
         Infectious Diseases
         Internal Medicine
         Surgery
         Oncology
         Biomedicine
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-023-01016-7/MediaObjects/40001_2023_1016_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-023-01016-7/MediaObjects/40001_2023_1016_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-023-01016-7/MediaObjects/40001_2023_1016_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-023-01016-7/MediaObjects/40001_2023_1016_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-023-01016-7/MediaObjects/40001_2023_1016_Fig5_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-023-01016-7/MediaObjects/40001_2023_1016_Fig6_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-023-01016-7/MediaObjects/40001_2023_1016_Fig7_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-023-01016-7/MediaObjects/40001_2023_1016_Fig8_HTML.png
      isPartOf:
         name:European Journal of Medical Research
         issn:
            2047-783X
         volumeNumber:28
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Jianping Zhang
            affiliation:
                  name:Medical School of Nantong University
                  address:
                     name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
                     type:PostalAddress
                  type:Organization
                  name:Affiliated Hospital of Nanjing University Medical School
                  address:
                     name:Department of Oncology, Yancheng First Hospital, Affiliated Hospital of Nanjing University Medical School, Yancheng, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jie Gao
            affiliation:
                  name:Medical School of Nantong University
                  address:
                     name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
                     type:PostalAddress
                  type:Organization
                  name:Affiliated Hospital of Nanjing University Medical School
                  address:
                     name:Department of Oncology, Yancheng First Hospital, Affiliated Hospital of Nanjing University Medical School, Yancheng, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mingchao Hu
            affiliation:
                  name:Medical School of Nantong University
                  address:
                     name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
                     type:PostalAddress
                  type:Organization
                  name:Medical School of Nantong University
                  address:
                     name:Department of Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Shiyu Xu
            affiliation:
                  name:Medical School of Nantong University
                  address:
                     name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Chun Cheng
            affiliation:
                  name:Medical School of Nantong University
                  address:
                     name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
                     type:PostalAddress
                  type:Organization
                  name:Medical School of Nantong University
                  address:
                     name:Department of Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Wenjie Zheng
            affiliation:
                  name:Medical School of Nantong University
                  address:
                     name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
                     type:PostalAddress
                  type:Organization
                  name:Medical School of Nantong University
                  address:
                     name:Department of Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Jie Zhang
            affiliation:
                  name:Medical School of Nantong University
                  address:
                     name:Department of Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:European Journal of Medical Research
      issn:
         2047-783X
      volumeNumber:28
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Medical School of Nantong University
      address:
         name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
         type:PostalAddress
      name:Affiliated Hospital of Nanjing University Medical School
      address:
         name:Department of Oncology, Yancheng First Hospital, Affiliated Hospital of Nanjing University Medical School, Yancheng, China
         type:PostalAddress
      name:Medical School of Nantong University
      address:
         name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
         type:PostalAddress
      name:Affiliated Hospital of Nanjing University Medical School
      address:
         name:Department of Oncology, Yancheng First Hospital, Affiliated Hospital of Nanjing University Medical School, Yancheng, China
         type:PostalAddress
      name:Medical School of Nantong University
      address:
         name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
         type:PostalAddress
      name:Medical School of Nantong University
      address:
         name:Department of Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
         type:PostalAddress
      name:Medical School of Nantong University
      address:
         name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
         type:PostalAddress
      name:Medical School of Nantong University
      address:
         name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
         type:PostalAddress
      name:Medical School of Nantong University
      address:
         name:Department of Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
         type:PostalAddress
      name:Medical School of Nantong University
      address:
         name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
         type:PostalAddress
      name:Medical School of Nantong University
      address:
         name:Department of Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
         type:PostalAddress
      name:Medical School of Nantong University
      address:
         name:Department of Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Jianping Zhang
      affiliation:
            name:Medical School of Nantong University
            address:
               name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
               type:PostalAddress
            type:Organization
            name:Affiliated Hospital of Nanjing University Medical School
            address:
               name:Department of Oncology, Yancheng First Hospital, Affiliated Hospital of Nanjing University Medical School, Yancheng, China
               type:PostalAddress
            type:Organization
      name:Jie Gao
      affiliation:
            name:Medical School of Nantong University
            address:
               name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
               type:PostalAddress
            type:Organization
            name:Affiliated Hospital of Nanjing University Medical School
            address:
               name:Department of Oncology, Yancheng First Hospital, Affiliated Hospital of Nanjing University Medical School, Yancheng, China
               type:PostalAddress
            type:Organization
      name:Mingchao Hu
      affiliation:
            name:Medical School of Nantong University
            address:
               name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
               type:PostalAddress
            type:Organization
            name:Medical School of Nantong University
            address:
               name:Department of Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
               type:PostalAddress
            type:Organization
      name:Shiyu Xu
      affiliation:
            name:Medical School of Nantong University
            address:
               name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
               type:PostalAddress
            type:Organization
      name:Chun Cheng
      affiliation:
            name:Medical School of Nantong University
            address:
               name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
               type:PostalAddress
            type:Organization
            name:Medical School of Nantong University
            address:
               name:Department of Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Wenjie Zheng
      affiliation:
            name:Medical School of Nantong University
            address:
               name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
               type:PostalAddress
            type:Organization
            name:Medical School of Nantong University
            address:
               name:Department of Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Jie Zhang
      affiliation:
            name:Medical School of Nantong University
            address:
               name:Department of Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
      name:Department of Oncology, Yancheng First Hospital, Affiliated Hospital of Nanjing University Medical School, Yancheng, China
      name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
      name:Department of Oncology, Yancheng First Hospital, Affiliated Hospital of Nanjing University Medical School, Yancheng, China
      name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
      name:Department of Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
      name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
      name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
      name:Department of Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
      name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
      name:Department of Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
      name:Department of Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China

External Links {🔗}(137)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Prism.js

4.11s.